Skip to main content

Table 1 Patient disease, staging and treatment (N = 248)

From: Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer

Diagnosis number of patient (%)

 Lymphoma 43 (17.7)

Gastric cancer 9 (3.6)

 Hepatobiliary cancer 38 (15.3)

Soft tissue sarcoma 9 (3.6)

 Lung cancer 27 (10.9)

Bone cancer 8 (3.2)

 Colon & rectal cancer 27 (10.9)

Bladder cancer 4 (1.5)

 Head and neck cancer 21 (8.4)

Prostate cancer 3 (1.2)

 Breast cancer 20 (8)

Testicular cancer 2 (0.8)

 Multiple myeloma 17 (6.9)

Esophageal cancer 2 (0.8)

 Leukemia 10 (4)

Othera 8 (3.2)

Stage of disease (%)

 Stage 1

6 (2.4)

 Stage 2

26 (10.1)

 Stage 3

45 (18.2)

 Stage 4

123 (49.6)

 Relapse

38 (15.3)

 Not relevant

10 (4.4)

Treatment (%)

 Chemotherapy

241 (97.2)

 CCRT

5 (2.0)

 Surgery

1 (0.4)

 Radiation

1 (0.4)

  1. aOther includes ovary, uterus, anal, CNS, pancreas, peritoneal, and unknown primary cancer
  2. CRRT Concurrent Chemotherapy and radiation